Free Trial

Regeneron Pharmaceuticals Top Holdings and 13F Report (2025)

About Regeneron Pharmaceuticals

Regeneron Pharmaceuticals NASDAQ: REGN has filed 13-F forms with the SEC as an investor. Regeneron Pharmaceuticals is itself a publicly traded company. For more information on Regeneron Pharmaceuticals stock, visit the Regeneron Pharmaceuticals stock profile here.

Investment Activity

  • Regeneron Pharmaceuticals has $1.23 billion in total holdings as of March 31, 2025.
  • Regeneron Pharmaceuticals owns shares of 6 different stocks, but just 1 company or ETF makes up 80% of its holdings.
  • This quarter, Regeneron Pharmaceuticals has purchased 6 new stocks and bought additional shares in 0 stocks.
  • Regeneron Pharmaceuticals sold shares of 0 stocks and completely divested from 0 stocks this quarter.

Largest Holdings

2seventy bio
$6,198,845
Adverum Biotechnologies, Inc.
$790,572
Adicet Bio
$730,978

Sector Allocation Over Time

Map of 500 Largest Holdings ofRegeneron Pharmaceuticals

 
 
Selling
 
 
Neutral
 
 
Buying
Issuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSector
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$1,200,089,0390.0%4,444,44597.2%Medical
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
$26,328,2940.0%3,702,9952.1%Medical
2seventy bio, Inc. stock logo
TSVT
2seventy bio
$6,198,8450.0%1,254,8270.5%Medical
Adverum Biotechnologies, Inc.
$790,5720.0%180,9090.1%Common Stock
Adicet Bio, Inc. stock logo
ACET
Adicet Bio
$730,9780.0%968,1830.1%Medical
Bluebird Bio, Inc.
$102,4800.0%21,0000.0%Common Stock

Showing largest 100 holdings. View all holdings.
SEC Filings and Trading Data